These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17627461)

  • 1. Clinical and therapeutic significance of aberrant differentiation patterns in bladder cancer.
    Black PC; Brown GA; Dinney CP
    Expert Rev Anticancer Ther; 2007 Jul; 7(7):1015-26. PubMed ID: 17627461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of variant histology on the outcome of bladder cancer treated with curative intent.
    Black PC; Brown GA; Dinney CP
    Urol Oncol; 2009; 27(1):3-7. PubMed ID: 18367107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection.
    Wasco MJ; Daignault S; Zhang Y; Kunju LP; Kinnaman M; Braun T; Lee CT; Shah RB
    Urology; 2007 Jul; 70(1):69-74. PubMed ID: 17656211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
    Shanks JH; Iczkowski KA
    Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological variants of invasive bladder cancer according to their suggested clinical significance.
    Lopez-Beltran A; Requena MJ; Cheng L; Montironi R
    BJU Int; 2008 Feb; 101(3):275-81. PubMed ID: 17986288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic transitional cell carcinoma: pathologic features and clinical management.
    Shen SS; Lerner SP
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer: clinical and pathological profile.
    Lopez-Beltran A
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):95-109. PubMed ID: 18815924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of World Health Organization/International Society of Urologic Pathology 2004 classification schema for bladder urothelial carcinomas using quantitative nuclear morphometry: identification of predictive features using bootstrap method.
    Kapur U; Antic T; Venkataraman G; Durazo-Arvizu R; Quek MM; Flanigan RC; Wojcik EM
    Urology; 2007 Nov; 70(5):1028-33. PubMed ID: 18068480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid urothelial carcinoma of the bladder.
    Lopez-Beltran A; Requena MJ; Montironi R; Blanca A; Cheng L
    Hum Pathol; 2009 Jul; 40(7):1023-8. PubMed ID: 19297008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urothelial carcinoma with abundant myxoid stroma.
    Tavora F; Epstein JI
    Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer.
    Kipp BR; Tyner HL; Campion MB; Voss JS; Karnes RJ; Sebo TJ; Halling KC; Zhang J
    Am J Clin Pathol; 2008 Oct; 130(4):552-9. PubMed ID: 18794047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma.
    Paner GP; Ro JY; Wojcik EM; Venkataraman G; Datta MW; Amin MB
    Am J Surg Pathol; 2007 Sep; 31(9):1420-9. PubMed ID: 17721199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?
    Scosyrev E; Yao J; Messing E
    Urology; 2009 Apr; 73(4):822-7. PubMed ID: 19193403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleomorphic giant cell carcinoma of the urinary bladder.
    Lopez-Beltran A; Blanca A; Montironi R; Cheng L; Regueiro JC
    Hum Pathol; 2009 Oct; 40(10):1461-6. PubMed ID: 19467692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive urothelial carcinoma of the bladder with glandular differentiation: report of 24 cases.
    Miller JS; Epstein JI
    Am J Surg Pathol; 2009 Aug; 33(8):1241-8. PubMed ID: 19440144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micropapillary pattern in urothelial carcinoma: a clinicopathological analysis.
    Alkibay T; Sözen S; Gürocak S; Işik Gönül I; Poyraz A; Ure I
    Urol Int; 2009; 83(3):300-5. PubMed ID: 19829030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.